Changing mealtimes could prevent type 2 diabetes
In a new study, researchers will examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.
Adaptation after heart transplantation: A framework for the future
Anna Forsberg, Professor of Transplant Nursing at Lund University and Chair of the ETAHP Committee at the ESOT, explores a key area of development in heart transplant nursing as part of the build-up to ESOT Congress 2021.
New framework to improve diagnosis and treatment of rare diseases
The new UK Rare Diseases Framework sets out to accelerate diagnosis and improve the treatment of rare diseases.
A new era in cardiac diagnosis
Justin Hall, GM and VP EMEA, iRhythm Technologies, explores how modern technology is helping to diagnose Atrial Fibrillation (AF).
The importance of supporting uniquely able bodied female athletes in uncertain times
Here, Mary Wilson, Paralympic athlete, shares her personal experience and health journey to highlight the importance of supporting disabled female athletes.
The beginning of the end for Type 1 diabetes: A new view from immunotherapy...
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.
Transmission of Diarrheagenic E. coli by plants
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, shares her expertise on the transmission of Diarrheagenic E. coli by plants.
Diabetes: How can we improve patient wellbeing & national health outcomes?
Claus Møldrup, DrugsDisclosed.com Founder and Former Professor in Social Pharmacy at the University of Copenhagen, turns the spotlight on diabetes and explores how to improve patient wellbeing and national health outcomes.
Suppressing the spread of COVID-19 in the Africa Region
Open Access Government was privileged to speak with Dr Mary Stephen again, Public Health Expert at the World Health Organization African Region, about suppressing the spread of COVID-19, remaining vigilant and effectively tackling any resurgence.
Canada: Far behind other G7 countries in eliminating new HIV infections
Gary Lacasse, Executive Director with Kelly Puddister and Patrick Wright from the Canadian AIDS Society, argue that Canada is far behind other G7 countries in eliminating new HIV infections, with a 25.3% increase in new cases reported between 2014 and 2018.
Brain conditions, mental and neurological alike
Prof Monica Di Luca, President, European Brain Council, sheds light on brain conditions, mental and neurological alike, starting with comment on the burdens presented.
A vision of a world free from the effects of multiple sclerosis
Dr Katie Howe, Research Communications Manager at the MS Society charts a vision of a world free from the effects of multiple sclerosis.
Dementia research in the UK and COVID-19
Samantha Benham-Hermetz, Director of Policy and Public Affairs at Alzheimer’s Research UK charts us through the priorities for dementia research in the UK in light of COVID-19.
How to fight diabetes with improved body composition
Here the InBody Clinical Team explain how improved body composition can help fight type 2 diabetes.
Dementia Tech: Overcoming barriers to innovation post-pandemic
Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.
Diagnosis of dementia: The impact of COVID-19
Dementia UK’s Head of Research and Publications, Dr Karen Harrison Dening, discusses her thoughts on the diagnosis of dementia and the impact of COVID-19 on this.
ICE detention centres withheld vaccines from child migrants
Over 12 US Immigration and Customs Enforcement (ICE) detention centres had multiple outbreaks of infectious disease - due to withholding vaccines for adult and child migrants.
Why do people with dementia often go missing?
New research by the University of East Anglia found that 70% of people with dementia go missing - but why?
Long haul COVID-19 survivors experience lasting skin problems
According to a new analysis, COVID-19 patients have shown lasting skin problems long after their initial infection has cleared.
The ‘herd immunity’ strategy for COVID-19 is dangerous and unfeasible
Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.
